Robert D. Galiano
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Articles (59)
Objective To evaluate the prevalence, access to care, and health outcomes of orofacial clefts (OFCs) among American Indian and Alaska Native (AI/AN) populations through a systematic review and meta-analysis. Design Systematic review and meta-analysis performed in accordance with PRISMA 2020 guidelines and registered with PROSPERO (CRD420251035364). Setting US-based population registries, hospital databases, and institutional or community-level retrospective studies involving AI/AN populations. Patients and Participants AI/AN individuals with OFCs compared with non-Hispanic White patients. Interventions Primary cleft lip and palate repair, secondary cleft-related procedures, and multidisciplinary cleft care. Main Outcome Measure(s) Prevalence of OFCs, timing of cleft surgery, discharge disposition, access to specialists, and qualitative determinants of disparities. Results Eighteen studies including more than 1985 AI/AN patients were identified. Meta-analysis of 5 studies estimated a pooled OFC prevalence of 15 per 10 000 live births (95% confidence interval: 5-49), with substantial heterogeneity ( I 2 = 99.8%). Individual studies reported significantly higher OFC prevalence in AI/AN populations compared to non-Hispanic Whites (odds ratio range: 1.44-2.68). Geographic maldistribution of craniofacial-trained surgeons, increased odds of nonhome discharge, and delayed cleft palate repair were consistently observed barriers. Qualitative analyses highlighted structural inequities, perceived racism, and lack of culturally responsive care as major contributors to disparities. Conclusions AI/AN populations face a disproportionately high burden of OFCs alongside structural barriers to timely, culturally competent care. Addressing these disparities requires community-engaged, multidisciplinary interventions that improve geographic access and integrate culturally responsive approaches to care.
Year:
2026
Objective To evaluate the readability of online patient education materials (PEMs) for cleft lip and/or palate and assess their alignment with recommended readability levels. Design This study is a systematic review and meta-analysis. Setting Literature search conducted in PubMed, Scopus, and Embase databases following PRISMA guidelines. Materials Studies evaluating online PEMs for cleft care with reported readability metrics, including Flesch-Kincaid Grade Level, Flesch Reading Ease, SMOG Index, or Gunning Fog Index. Interventions Assessment of readability metrics of online PEMs and evaluation of artificial intelligence tools (eg, ChatGPT) for text simplification. Main Outcome Measure(s) Pooled readability estimates (eg, Flesch-Kincaid Grade Level, Flesch Reading Ease, SMOG Index, Gunning Fog Index), heterogeneity (I²), and confidence intervals (CIs). Results Nine studies were included, consistently showing that PEMs exceed readability recommendations. Pooled estimates revealed a Flesch-Kincaid Grade Level of 9.48 (95% CI: 8.51-10.45), Flesch Reading Ease score of 52.98 (95% CI: 42.62-63.34), SMOG Index of 9.27 (95% CI: 5.97-12.57), and Gunning Fog Index of 9.94 (95% CI: 8.90-10.98). Heterogeneity was minimal ( I ² = 0%). Artificial intelligence tools like ChatGPT demonstrated potential in simplifying text to the recommended sixth-grade reading level but lacked usability and comprehension testing. Conclusions Online PEMs for cleft care are consistently written at reading levels too complex for the average caregiver, underscoring the need for improved readability and accessibility. Future research should focus on developing multimodal resources, conducting usability assessments, and including non-English materials to address global disparities in cleft care education.
Year:
2026
Objective To systematically evaluate disparities in access, timing, and outcomes of cleft care for Hispanic/Latino patients in the United States. Design Systematic review and random-effects meta-analysis conducted per PRISMA guidelines (PROSPERO CRD420251053224). Setting US-based studies using national databases, state registries, and institutional cohorts. Patients, Participants Hispanic/Latino children with cleft lip and/or palate compared to non-Hispanic White children. Interventions Primary cleft lip and palate repair and secondary cleft-related procedures, including alveolar bone grafting. Main Outcome Measure(s) Timing of surgical interventions, postoperative complications, mortality, hospital charges, secondary procedure utilization, and patient-reported outcomes. Results Twenty-eight studies encompassing 30,006 Hispanic/Latino patients met inclusion criteria. Eight studies addressed surgical timing: Hispanic/Latino patients had significantly delayed primary repairs (eg, adjusted hazard ratio [aHR] 0.90 for cleft lip repair; odds ratio [OR] 2.76 for delayed palate repair) and higher rates of bone grafting after age 12 (24.4% vs. 19.4%, P = .0049). Three studies reported mixed patterns of secondary procedure utilization, with underuse of some operations (OR 0.29 for higher surgery frequency) but overrepresentation in cleft rhinoplasty (OR 1.36). Two national datasets showed elevated cleft-related mortality (OR 1.54; HR 1.3-1.7). While postoperative complication rates were largely equivalent, Hispanic/Latino patients experienced longer hospital stays and higher charges in several analyses. Meta-analysis of 2 studies on delayed surgery yielded a pooled OR of 2.11 (95% confidence interval 0.23-19.80) with low heterogeneity but wide uncertainty. Conclusions Hispanic/Latino patients face multifaceted disparities in cleft care—particularly delayed surgery and fragmented follow up—despite comparable technical outcomes. Targeted interventions addressing structural, linguistic, and cultural barriers are needed to advance equity in cleft treatment.
Year:
2026
Year:
2026
Year:
2026
Year:
2026
Epidemiologic and preclinical studies suggest a potential protective effect of breast implants against breast cancer, but underlying mechanisms remain unclear. The authors hypothesize that local inflammation after breast implant placement induces immunosurveillence. The authors of this study investigated whether serum from implant-exposed (IE) women reduced breast cancer cell viability compared with implant-naive (IN) women, and whether antibodies mediated this effect. Serum from IE and IN women with high or low antibody levels against estrogen receptor-alpha, mucin-1, or mammaglobin-A was incubated with cancer cell lines overexpressing each antigen (MCF7, T47D, and SKBR3, respectively). 3-(4,5-Dimethylthiazol-2-yl)-2,5-Diphenyltetrazolium Bromide (MTT) assays measured cell viability. Rescue experiments utilized recombinant antigen to neutralize antibodies. Thirty-six patients were enrolled, and 12 samples were used to assess viability for each cell line. Serum with high antibody concentrations reduced cell viability compared with serum with low antibody concentrations across all cell lines. IE serum reduced cell viability compared with IN serum across all cell lines. Rescue experiments reversed differences between high and low antibody serum, as well as between IE and IN serum, implicating antibodies as the mediators of reduced viability. Peripheral serum from IE women decreased breast cancer cell viability compared with IN women, even when matched for the same antibody levels. Antibody neutralization reversed differences. This suggests implant exposure altered antibody function or other serum components. These findings support the hypothesis that the inflammatory response to breast implants may increase breast cancer immunosurveillance, although significantly more work is needed to confirm a mechanism. Level of Evidence: 3 (Therapeutic)
Year:
2026
Year:
2026
Year:
2026
Year:
2026
Year:
2026
Year:
2026
Year:
2026
Year:
2026
Year:
2026
Year:
2026
Year:
2026
Year:
2026
Year:
2026
Year:
2026
Year:
2026
Year:
2026
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2023
Year:
2023
Year:
2023
Year:
2023
Collaborators (4)
Arun K. Gosain
Children's Service Board Professor and Chief, Division of Plastic Surgery
Northwestern University Feinberg School of Medicine
Dennis Orgill
Medical Director, Wound Care Center, Plastic Surgeon
Brigham and Women's Hospital
Adrian E. Rodrigues, MD
Northwestern University
Marco Ellis
Assistant Professor
Northwestern University Feinberg School of Medicine
Make your next move.
Prepare your application
Review drafts before you send them.